US · Consumer Cyclical · Specialty Retail
EPS came in at 0.32 against a street estimate of 0.29 — a beat of 10.3%.
Analysts rate Bath & Body Works Inc. a buy (11 buy, 8 hold, 1 sell out of 20) with an average price target of $25.20.
| Fund | Stake |
|---|---|
| FMR Inc | 10.36% |
| BlackRock Inc | 9.59% |
| Vanguard Portfolio Management, LLC | 7.45% |
| AQR Capital Management LLC | 5.48% |
| D. E. Shaw & Co LP | 4.72% |
| Vanguard Capital Management, LLC | 4.54% |
| State Street Corp | 3.44% |
| AllianceBernstein L.P. | 2.85% |
| Document | Date |
|---|---|
| Reg FD disclosure · Q3 2026 | 2026-07-20 |
| Shareholder vote results · Q2 2026 | 2026-06-15 |
| Quarterly report · Q2 2026 | 2026-05-27 |
| Results announced · Q2 2026 | 2026-05-27 |
| Proxy statement · Q2 2026 | 2026-04-28 |
| Annual report FY2026 | 2026-03-12 |
| Results announced · Q1 2026 | 2026-03-04 |
| Quarterly report · Q4 2025 | 2025-11-20 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Bath & Body Works Inc. — free to start.
Google PlayApp StoreData updated 2026-08-05.